Chen Irwin
Amgen
2 Papers
2 Citations
Chen Irwin is an academic researcher from Amgen. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Patent
Antibody constructs for cldn18.2 and cd3
Christoph Dahlhoff,Bluemel Claudia,Brozy Johannes,Raum Tobias,Elisabeth Nahrwold,Arvedson Tara,Chen Irwin,Ross Sandra,Bailis Julie +8 more
- 02 Aug 2019
TL;DR: In this article, an antibody construct comprising a domain which binds to Claudin 18.2 (CLDN18.2) and another domain that binds to CD3 (CD3).
2
Patent
Bispecific antibody construct directed to muc17 and cd3
Raum Tobias,Arvedson Tara,Bailis Julie,Christoph Dahlhoff,Ross Sandra,Chen Irwin,Bluemel Claudia,Elisabeth Nahrwold,Jochen Pendzialek,Joachim Wahi +9 more
- 31 Dec 2018
TL;DR: In this article, bispecific antibody constructs characterized by comprising a first domain binding to MUC17, a second domain bounding to an extracellular epitope of the human and the Macaca CD3e chain and optionally a third domain, which is a specific Fc modality.